Abstract
Purpose: This study reports on the results from our data-driven approach that identified perturbations in neuroactive ligand-receptor interaction and renin-angiotensin system (RAS) pathways in oncology patients with and without self-reported cancer-related cognitive impairment (CRCI).
Methods: In a sample of oncology patients receiving chemotherapy (n = 1343), the Attentional Function Index (AFI) was used to assess CRCI. Patients were grouped into low (AFI score of < 5) versus high (AFI score of > 7.5) levels of cognitive function. Gene expression analyses were done using RNA-seq (n = 185) and microarray (n = 158) technologies. Pathway impact analysis was used to evaluate for perturbations in biological pathways associated with self-reported CRCI.
Results: The combined pathway impact analysis revealed that the neuroactive ligand-receptor interaction and RAS pathways were significantly perturbed between the patients with low versus high AFI scores.
Conclusions: Findings from this study suggest that in addition to inflammatory pathways, numerous mechanisms may contribute to the underlying mechanisms for the development and/or persistence of self-reported CRCI.
| Original language | English |
|---|---|
| Article number | 254 |
| Number of pages | 9 |
| Journal | Supportive Care in Cancer |
| Volume | 33 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Apr 2025 |
Keywords
- Cancer
- Chemotherapy
- Cognitive dysfunction
- Cognitive impairment
- Neuroinflammation
- Renin angiotensin system